Dr Robert Kaladish, MD | |
109 Ponemah Rd, Ste D, Amherst, NH 03031-2834 | |
(603) 673-5558 | |
Not Available |
Full Name | Dr Robert Kaladish |
---|---|
Gender | Male |
Speciality | Psychiatry |
Experience | 41 Years |
Location | 109 Ponemah Rd, Amherst, New Hampshire |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1225103195 | NPI | - | NPPES |
30005553 | Medicaid | NH |
Mailing Address | Practice Location Address |
---|---|
Dr Robert Kaladish, MD Po Box 130, Wilton, NH 03086-0130 Ph: (603) 673-5558 | Dr Robert Kaladish, MD 109 Ponemah Rd, Ste D, Amherst, NH 03031-2834 Ph: (603) 673-5558 |
News Archive
A new study using organ-on-a-chip technology reveals how overactive immune cells aggravate heart valve disease and how this damaging hyperactivity could potentially be controlled.
Substantial proportions of parents chose urgent care or emergency department visits when their sick children were excluded from attending child care, according to a new study by University of Michigan researchers.
The U.S. Food and Drug Administration (FDA) Advisory Committee on Cardiovascular and Renal Drugs voted to recommend the approval of tolvaptan, Otsuka Pharmaceutical Development & Commercialization, Inc.'s (OPDC) investigational treatment for patients with hyponatremia.
The world's most significant coronavirus disease (COVID-19) vaccine study is underway in the United States, with a planned 30,000 volunteers. The phase 3 clinical trial aims to examine the efficacy and safety of the candidate vaccine developed by the National Institutes of Health and Moderna Inc.
› Verified 3 days ago